Shahnaz Shahinfar - Concepedia

Author

Shahnaz Shahinfar

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

S Shahinfar, Shahinfar, Shahnaz, Shahnaz Shahinfar

Publications

15.1K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Brigham and Women's Hospital United States Military Academy University Medical Center Groningen University of Groningen

About

Shahnaz Shahinfar is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	27	4.6K
2	Diabetes	17	18	3.9K
3	Public Health	6	6	664
4	Biostatistics	2	2	223
5	Emergency Medicine	1	1	108

Shahnaz Shahinfar

Publications

13.8K

Citations

H-Index

Page 1

	Year	Citations
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw, New England Journal of Medicine	2001	7.4K
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL Dick de Zeeuw, Giuseppe Remuzzi, Hans‐Henrik Parving, Kidney International Glomerular DiseaseGlomerulonephritisUrologyRenal DiseaseRenal Function	2004	963
Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy Dick de Zeeuw, Giuseppe Remuzzi, Hans‐Henrik Parving, Circulation	2004	749
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study William F. Keane, Barry M. Brenner, Dick de Zeeuw, Kidney International HemodialysisUrologyRenal DiseaseRenal FunctionMedicine	2003	542
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease Tazeen H. Jafar, Paul C. Stark, Christopher H. Schmid, Kidney International GlomerulonephritisUrologyRenal DiseaseRenal FunctionMedicine	2001	378
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function Frank A. Holtkamp, Dick de Zeeuw, Merlin C. Thomas, Kidney International Glomerular DiseaseHemodialysisUrologyRenal FunctionSlower Decrease	2011	341
Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy Wouter B.A. Eijkelkamp, Zhongxin Zhang, Giuseppe Remuzzi, Journal of the American Society of Nephrology HypertensionAlbuminuria ReductionBlood PressureGlomerulonephritisRenal Function	2007	299
Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy Anupama Mohanram, Zhongxin Zhang, Shahnaz Shahinfar, Kidney International GlomerulonephritisHemodialysisUrologyRenal DiseaseRenal Function	2004	236
Retinal Neovascularization Is Prevented by Blockade of the Renin-Angiotensin System Christina J. Moravski, Darren J. Kelly, Mark E. Cooper, Hypertension HypertensionOcular DiseaseReceptor AntagonistRetinal Neovascularization IsRetina	2000	225
Relative Incidence of ESRD Versus Cardiovascular Mortality in Proteinuric Type 2 Diabetes and Nephropathy: Results From the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) Database David Packham, Tahira P. Alves, Jamie P. Dwyer, American Journal of Kidney Diseases Metabolic SyndromeUrologyRenal DiseaseRenal FunctionHealth Policy	2011	204

Page 1